PAHC
Phibro Animal Health Corporation
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Last price
36.28
▲ 1.10 (3.13%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
35.18
Prev close
35.18
Day high
36.44
Day low
35.29
Volume
318.65K
Market cap
$1.47B
P/E (TTM)
15.59
52W range
28.25 – 60.08
Insider net activity
Net shares
+68.37K
Net buying
Buy transactions
11
248.90K shares
Sell transactions
10
180.53K shares
Net transactions
+21
Buys less sells
Sell : buy shares
0.7 : 1
Mixed
Insider-held shares
351.70K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 6, 26 | BENDHEIM JACK C Officer, Director and Beneficial Owner |
STOCK | 12.10K | $0 | Direct |
| Aug 6, 26 | MILLER LARRY LEE Chief Operating Officer |
STOCK | 3.52K | $0 | Direct |
| Aug 6, 26 | BENDHEIM DANIEL M Chief Executive Officer |
STOCK | 11.70K | $0 | Direct |
| Aug 6, 26 | DAVID GLENN C Chief Financial Officer |
STOCK | 3.33K | $0 | Direct |
| Aug 6, 26 | ESCUDERO LISA ANN Officer |
STOCK | 1.55K | $0 | Direct |
| Aug 6, 26 | BENDHEIM JONATHAN Director |
STOCK | 2.72K | $0 | Direct |
| Aug 6, 26 | WEINSTEIN JUDITH General Counsel |
STOCK | 2.48K | $0 | Direct |
| Aug 6, 26 | RODRIGUEZ PATRICK Officer and Treasurer |
STOCK | 1.50K | $0 | Direct |
| May 29, 26 | CORCORAN E. THOMAS Director |
BUY | 10.00K | $317.70K | Direct |
| May 7, 26 | BENDHEIM JACK C Chief Executive Officer |
SELL | 18.61K | $1.02M | Indirect |
| Apr 30, 26 | BENDHEIM JACK CLIFFORD Chief Executive Officer |
SELL | 21.12K | $1.14M | Indirect |
| Apr 23, 26 | BENDHEIM JACK C Chief Executive Officer |
SELL | 21.12K | $1.16M | Indirect |
| Apr 16, 26 | BENDHEIM JACK C Chief Executive Officer |
SELL | 21.12K | $1.20M | Indirect |
| Apr 16, 26 | BENDHEIM JACK C Chief Executive Officer |
— | 100.00K | — | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDOLINO ANTHONY |
Officer and Treasurer | 1.79K | Stock Award(Grant) |
BENDHEIM DANIEL M |
Chief Executive Officer | 15.18K | Stock Award(Grant) |
BENDHEIM JACK C |
Officer, Director and Beneficial Owner | 82.79K | Stock Award(Grant) |
BENDHEIM JACK CLIFFORD |
Chief Executive Officer | — | Sale |
BENDHEIM JONATHAN |
Director | 5.98K | Stock Award(Grant) |
CORCORAN E. THOMAS |
Director | 41.46K | Purchase |
DAVID GLENN C |
Chief Financial Officer | 54.81K | Stock Award(Grant) |
ESCUDERO LISA ANN |
Officer | 3.43K | Stock Award(Grant) |
MILLER LARRY LEE |
Chief Operating Officer | 38.07K | Stock Award(Grant) |
WEINSTEIN JUDITH |
General Counsel | 5.45K | Stock Award(Grant) |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.97
Call-heavy session
Put / call open interest
2.09
Positioning, not flow
Max pain
35.00
-3.6% from spot
ATM implied vol
90.4%
Nearest strike to spot
Skew (10% OTM)
+87.9%
Puts bid over calls
Call volume
59
Contracts, this expiry
Put volume
57
Contracts, this expiry
Heaviest call OI
35.00
82 contracts
Heaviest put OI
30.00
463 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+5.70%
+7.1%
1M
+6.70%
+3.0%
3M
+8.55%
+5.5%
6M
-31.21%
-42.3%
YTD
-2.78%
-15.1%
1Y
+16.63%
-3.4%
3Y
+140.21%
+66.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.47B
Enterprise value$2.18B
Revenue (TTM)$1.50B
Gross profit$488.62M
EBITDA$234.75M
Net income$95.23M
EPS (TTM)$2.33
Free cash flow$-17.68M
Total cash$78.14M
Total debt$788.68M
Book value / share$8.92
Shares outstanding21.07M
Float20.87M
Short % of float6.73%
Dividend yield1.32%
Beta (5Y)0.46
Short interest
Shares short
1.19M
Prior 1.22M
Change vs prior
-2.0%
Shorts covering
% of float
6.73%
Normal
% of shares out
2.94%
Against total outstanding
Days to cover
4.5
Liquid
Float
20.87M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E15.59
Forward P/E10.86
PEG ratio1.68
Price / sales—
Price / book4.07
EV / revenue1.46
EV / EBITDA9.30
Gross margin32.57%
Operating margin12.56%
Profit margin6.35%
Return on equity30.34%
Return on assets8.40%
Debt / equity217.97
Current ratio3.17
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.30B | $1.02B | $977.89M | $942.26M | +27.4% |
| Operating revenue | $1.30B | $1.02B | $977.89M | $942.26M | +27.4% |
| Cost of revenue | $896.27M | $704.59M | $679.65M | $656.86M | +27.2% |
| Gross profit | $399.94M | $313.09M | $298.24M | $285.40M | +27.7% |
| Selling, general & admin | $289.48M | $259.78M | $226.39M | $206.41M | +11.4% |
| Total operating expense | $289.48M | $259.78M | $226.39M | $206.41M | +11.4% |
| Operating income | $110.47M | $53.31M | $71.85M | $78.99M | +107.2% |
| Net interest income | -$34.60M | -$18.54M | -$15.32M | -$11.88M | -86.7% |
| Pre-tax income | $67.99M | $10.92M | $54.07M | $72.33M | +522.9% |
| Tax provision | $19.73M | $8.50M | $21.46M | $23.15M | +132.1% |
| Net income | $48.26M | $2.42M | $32.61M | $49.17M | +1,897.7% |
| Net income to common | $48.26M | $2.42M | $32.61M | $49.17M | +1,897.7% |
| Basic EPS | 1.19 | 0.06 | 0.81 | 1.21 | +1,883.3% |
| Diluted EPS | 1.19 | 0.06 | 0.81 | 1.21 | +1,883.3% |
| EBIT | $101.24M | $32.89M | $72.02M | $84.43M | +207.9% |
| EBITDA | $146.85M | $69.06M | $106.03M | $117.13M | +112.6% |
| Basic shares | 40.50M | 40.50M | 40.50M | 40.50M | -0.0% |
| Diluted shares | 40.70M | 40.52M | 40.50M | 40.50M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $68.04M | $70.61M | $41.28M | $74.25M | -3.6% |
| Cash & short-term investments | $77.04M | $114.61M | $81.28M | $91.25M | -32.8% |
| Accounts receivable | $227.98M | $169.45M | $163.48M | $166.54M | +34.5% |
| Inventory | $444.43M | $265.91M | $277.57M | $259.16M | +67.1% |
| Total current assets | $810.61M | $601.00M | $585.72M | $566.23M | +34.9% |
| Property, plant & equipment | $396.03M | $240.90M | $231.33M | $203.17M | +64.4% |
| Goodwill & intangibles | $96.11M | $99.59M | $108.26M | $117.09M | -3.5% |
| Total assets | $1.36B | $982.18M | $971.40M | $931.70M | +38.6% |
| Total current liabilities | $293.47M | $204.15M | $176.00M | $190.83M | +43.8% |
| Current debt | $16.25M | $29.80M | $22.30M | $15.00M | -45.5% |
| Long-term debt | $702.43M | $458.29M | $452.54M | $417.93M | +53.3% |
| Total debt | $761.55M | $525.46M | $509.97M | $470.48M | +44.9% |
| Total liabilities | $1.08B | $725.54M | $688.89M | $669.26M | +48.2% |
| Retained earnings | $272.70M | $243.89M | $260.91M | $247.75M | +11.8% |
| Shareholder equity | $285.68M | $256.64M | $282.51M | $262.44M | +11.3% |
| Working capital | $517.13M | $396.85M | $409.72M | $375.40M | +30.3% |
| Net tangible assets | $189.57M | $157.05M | $174.25M | $145.35M | +20.7% |
| Shares issued | 40.53M | 40.50M | 40.50M | 40.50M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $48.26M | $2.42M | $32.61M | $49.17M | +1,897.7% |
| Depreciation & amortisation | $45.60M | $36.18M | $34.01M | $32.70M | +26.1% |
| Stock-based compensation | $717.00K | $475.00K | $0 | $0 | +50.9% |
| Change in working capital | -$21.56M | $33.11M | -$41.13M | -$44.64M | -165.1% |
| Operating cash flow | $80.12M | $87.59M | $13.31M | $31.65M | -8.5% |
| Capital expenditure | -$38.29M | -$41.24M | -$51.79M | -$37.04M | +7.1% |
| Investing cash flow | -$288.69M | -$48.19M | -$74.02M | -$22.58M | -499.0% |
| Dividends paid | -$19.45M | -$19.44M | -$19.44M | -$19.44M | -0.0% |
| Financing cash flow | $207.13M | -$6.77M | $26.99M | $16.34M | +3,160.5% |
| Free cash flow | $41.83M | $46.36M | -$38.48M | -$5.39M | -9.8% |
| End cash position | $68.04M | $70.61M | $41.28M | $74.25M | -3.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $383.54M | $373.91M | $363.89M | $378.70M | $347.82M | +2.6% |
| Operating revenue | $383.54M | $373.91M | $363.89M | $378.70M | $347.82M | +2.6% |
| Cost of revenue | $257.87M | $241.25M | $244.11M | $268.69M | $243.26M | +6.9% |
| Gross profit | $125.67M | $132.66M | $119.78M | $110.01M | $104.57M | -5.3% |
| Selling, general & admin | $81.02M | $82.33M | $68.52M | $76.29M | $71.05M | -1.6% |
| Total operating expense | $81.02M | $82.33M | $68.52M | $76.29M | $71.05M | -1.6% |
| Operating income | $44.65M | $50.33M | $51.26M | $33.72M | $33.52M | -11.3% |
| Net interest income | -$10.43M | -$11.76M | -$12.06M | -$8.61M | -$9.36M | +11.3% |
| Pre-tax income | $32.31M | $36.42M | $36.27M | $23.85M | $29.69M | -11.3% |
| Tax provision | $8.29M | $8.97M | $9.74M | $6.62M | $8.81M | -7.6% |
| Net income | $24.02M | $27.46M | $26.53M | $17.22M | $20.88M | -12.5% |
| Net income to common | $24.02M | $27.46M | $26.53M | $17.22M | $20.88M | -12.5% |
| Basic EPS | 0.59 | 0.68 | 0.65 | 0.42 | 0.52 | -13.2% |
| Diluted EPS | 0.59 | 0.67 | 0.65 | 0.42 | 0.51 | -11.9% |
| EBIT | $42.42M | $48.27M | $48.24M | $32.30M | $38.77M | -12.1% |
| EBITDA | $54.87M | $61.16M | $61.07M | $44.71M | $51.38M | -10.3% |
| Basic shares | 40.55M | 40.53M | 40.53M | 40.50M | 40.50M | +0.0% |
| Diluted shares | 41.04M | 40.96M | 40.88M | 40.70M | 40.70M | +0.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.93M | $55.49M | $72.77M | $68.04M | $60.35M | -1.0% |
| Cash & short-term investments | $77.45M | $74.51M | $85.27M | $77.04M | $70.35M | +3.9% |
| Accounts receivable | $221.55M | $215.87M | $217.90M | $227.98M | $197.52M | +2.6% |
| Inventory | $539.70M | $517.35M | $471.77M | $444.43M | $448.39M | +4.3% |
| Total current assets | $894.07M | $862.18M | $835.80M | $810.61M | $776.02M | +3.7% |
| Property, plant & equipment | $408.51M | $394.80M | $394.93M | $396.03M | $378.33M | +3.5% |
| Goodwill & intangibles | $91.57M | $92.88M | $94.67M | $96.11M | $92.34M | -1.4% |
| Total assets | $1.45B | $1.41B | $1.39B | $1.36B | $1.32B | +2.8% |
| Total current liabilities | $281.87M | $282.37M | $270.14M | $293.47M | $266.48M | -0.2% |
| Current debt | $22.83M | $20.64M | $18.44M | $16.25M | $16.25M | +10.6% |
| Long-term debt | $712.68M | $710.60M | $724.52M | $702.43M | $711.16M | +0.3% |
| Total debt | $787.44M | $773.17M | $785.10M | $761.55M | $770.02M | +1.8% |
| Total liabilities | $1.08B | $1.07B | $1.07B | $1.08B | $1.05B | +0.9% |
| Retained earnings | $336.12M | $316.96M | $294.36M | $272.70M | $260.34M | +6.0% |
| Shareholder equity | $361.83M | $332.36M | $311.68M | $285.68M | $265.99M | +8.9% |
| Working capital | $612.20M | $579.82M | $565.66M | $517.13M | $509.54M | +5.6% |
| Net tangible assets | $270.25M | $239.48M | $217.01M | $189.57M | $173.66M | +12.8% |
| Shares issued | 40.56M | 40.53M | 40.53M | 40.53M | 40.53M | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $24.02M | $27.46M | $26.53M | $17.22M | $20.88M | -12.5% |
| Depreciation & amortisation | $12.45M | $12.89M | $12.83M | $12.41M | $12.62M | -3.4% |
| Stock-based compensation | $411.00K | $434.00K | $339.00K | $179.00K | $179.00K | -5.3% |
| Change in working capital | -$26.71M | -$25.09M | -$33.54M | -$14.25M | $8.43M | -6.5% |
| Operating cash flow | $16.21M | $19.35M | $9.30M | $21.27M | $43.15M | -16.3% |
| Capital expenditure | -$15.32M | -$11.10M | -$13.81M | -$13.14M | -$7.75M | -38.0% |
| Investing cash flow | -$16.81M | -$17.18M | -$21.01M | -$7.03M | -$18.25M | +2.2% |
| Dividends paid | -$4.87M | -$4.86M | -$4.86M | -$4.86M | -$4.87M | -0.1% |
| Financing cash flow | -$2.30M | -$18.98M | $16.34M | -$7.77M | -$32.22M | +87.9% |
| Free cash flow | $890.00K | $8.26M | -$4.50M | $8.13M | $35.41M | -89.2% |
| End cash position | $54.93M | $55.49M | $72.77M | $68.04M | $60.35M | -1.0% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2026 | 0.71 | 0.76 | +6.5% |
| Dec 2025 | 0.67 | 0.87 | +29.8% |
| Sep 2025 | 0.60 | 0.73 | +21.1% |
| Jun 2025 | 0.52 | 0.57 | +9.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.73 | 4 | $378.33M | -0.1% |
| Next quarter | 0.79 | 1 | $0 | — |
| Current year | 3.07 | 5 | $1.50B | +15.6% |
| Next year | 3.34 | 5 | $1.55B | +3.3% |
Analyst targets & ownership
Mean target$45.00
High target$58.00
Low target$35.00
Implied upside24.04%
Analyst count5
ConsensusHOLD
Strong buy / Buy1 / 0
Hold3
Sell / Strong sell0 / 1
Held by insiders0.87%
Held by institutions103.63%
Institutions holding311
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 14, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Apr 15, 26 | Citigroup | INITIATED | — | Neutral |
| Nov 7, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 29, 25 | B of A Securities | MAINTAINED | Underperform | Underperform |
| Jul 7, 25 | JP Morgan | UPGRADE | Neutral | Overweight |
| Jun 25, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| May 8, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 10, 25 | Barclays | MAINTAINED | Underweight | Underweight |
| Dec 17, 24 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Nov 12, 24 | Barclays | MAINTAINED | Underweight | Underweight |
| Sep 10, 24 | JP Morgan | INITIATED | — | Neutral |
| Aug 30, 24 | B of A Securities | MAINTAINED | Underperform | Underperform |
Moving averages & technicals
SMA 10
34.67
+4.65% from price
SMA 20
35.38
+2.66% from price
SMA 50
33.66
+7.92% from price
SMA 100
39.45
-8.03% from price
SMA 200
42.20
-13.93% from price
EMA 12
35.07
+3.44% from price
EMA 26
34.80
+4.24% from price
EMA 50
35.27
+2.87% from price
RSI (14)
61.2
Neutral
MACD (12,26,9)
0.27
Hist 0.03
ATR (14)
1.34
3.68% of price
Realised vol 30D
29.2%
Annualised
Bollinger upper
37.49
20, 2σ
Bollinger lower
33.27
20, 2σ
50 / 200 cross
Death
33.66 vs 42.20
Trend bias
Below 200
-13.93%
Risk profile
Beta vs SPY
0.96
Less volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
29.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-52.1%
Peak to trough
Max drawdown 5Y
-61.8%
Peak to trough
ATR 14
1.34
3.68% of price
Beta (reported)
0.46
5Y monthly, from filing
Dividends & splits
Forward rate$0.48 / yr
Forward yield1.32%
5-year avg yield2.55%
Payout ratio20.60%
Ex-dividend dateSep 2, 2026
Next pay dateSep 23, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-07-28
Corporate Changes & Voting Matters
8-K · 2026-06-26
Corporate Changes & Voting Matters
8-K · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-05-05
Corporate Changes & Voting Matters
8-K · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-04-27
Corporate Changes & Voting Matters
8-K · 2026-04-14
Corporate Changes & Voting Matters
8-K · 2026-02-04
Headlines
Phibro (PAHC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Zacks · 1d ago
Is Phibro Animal Health (PAHC) Still Reasonable After A 149% Run?
Simply Wall St. · 2d ago
Phibro Animal Health (PAHC) Could Be 22% Undervalued On Upcoming Earnings
Simply Wall St. · 2d ago
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2026 Results
Business Wire · 3d ago
Should You Continue to Retain PAHC Stock in Your Portfolio?
Zacks · 3d ago
2 Small-Cap Stocks with Solid Fundamentals and 1 We Avoid
StockStory · 4d ago
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
Zacks · 10d ago
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Zacks · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.